| Purity: | 99 |
|---|---|
| Model Number: | 1197-18-8 |
| Brand Name: | NJBN STEROID |
| Grade Standard: | Medicine Grade |
| Type: | Immune Function Agents |
| Place of Origin: | China (Mainland) |
| EINECS No.: | NJBN STEROID |
| MF: | C8H15NO2 |
| Other Names: | Amstat |
| CAS No.: | 1197-18-8 |
| Sample: | Free |
| Market: | Worldwide |
Quick Details
Specifications
Amstat 1197-18-8 For Prevent Excessive Blood Loss
Product Name: Amstat
Synonyms: TIMTEC-BB SBB006715;TRANS-4-AMINOMETHYL-1-CYCLOHEXANECARBOXYLIC ACID;trans-4-aminomethylcyclohexane-1-carboxylate;TRANS-4-(AMINOMETHYL)CYCLOHEXANECARBOXYLIC ACID;TRANEXAMIC ACID;amstat;amcha;amikapron
CAS: 1197-18-8
MF: C8H15NO2
MW: 157.21
EINECS: cChemical Properties white crystalline powder
Usage Antifibrinolytic agent; blocks lysine binding sites of plasminogen. Hemostatic.
Usage Used as a lysine analogue to characterize binding sites in plasminogen.1,2
COA
|
Items of analysis |
Specification |
Results |
|
Appearance |
White crystalline powder |
White crystalline powder |
|
Solubility |
Soluble in water and glacial acetic acid, almost not soluble in ethanol and acetone (96%) |
Soluble in water and glacial acetic acid, almost not soluble in ethanol and acetone (96%) |
|
Identification |
Infrared absorption map complies with the tranexamic acid comparison map |
Infrared absorption map complies with the tranexamic acid comparison map |
|
PH |
7.0～8.0 |
7.25 |
|
Loss on drying |
≤0.5% |
0.06% |
|
Residue on ignition |
≤0.1% |
0.01% |
|
Heavy metals |
≤10ppm |
＜10ppm |
|
Sulphate ash |
≤0.1% |
＜0.07% |
|
Chloride |
≤140ppm |
＜140ppm |
|
Arsenic |
≤2ppm |
＜2ppm |
|
Related substances |
A≤0.1%, B≤0.2%, C≤0.1%, D≤0.1% |
A=0.031%, B=0.0812% , C=0.0095%, D=0.0066% |
|
Total impurities |
(except A,B) ≤0.2% |
Total impurities(except A,B)=0.015% |
|
Assay |
99.0%～101.0% |
99.8% |
|
Conclusion |
Qualified |
|
Description:Tranexamic acid is a medication used to treat or prevent excessive blood loss from trauma, surgery, and in various medical conditions including hemophilia and heavy menstrual bleeding. It comes in oral and intravenous forms.
Side effects are uncommon and include gastrointestinal effects, dizziness, fatigue, headache, and hypersensitivity reactions.The medication needs to be used cautiously in people with kidney disease and who are at a high risk for blood clots. Tranexamic is safe to use in pregnant women. However, caution should be used in lactating women.[1] It is an antifibrinolytic.
It was discovered in 1962 by Utako Okamoto and has been on the World Health Organization's List of Essential Medicines, the most important medications needed in a basic health system.
